Processa Pharmaceuticals, Inc. (PCSA) stock

PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30

$1.86+0.02 (+1.09%)

Close on Nov 13, 2026Market cap $5.20MP/E –Yield –

Processa Pharmaceuticals operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2016 it was -38430.4%.

Period	Period end	Value	Change (pts)
FY2016	Dec 31, 2016	-38430.4%	–

See a number that looks wrong?